8th German Pharm-Tox Summit

Prof. Dr.

Prof. Dr. Dr.

Potential influence of cancer-patient derived mutations in the MAP kinase negative regulator DUSP2 (dual-specificity phosphatase 2) on phosphatase activity

Cancer pharmacology	

Pharmacogenomics and personalized medicine	

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Potential influence of cancer-patient derived mutations in the MAP kinase negative regulator DUSP2 (dual-specificity phosphatase 2) on phosphatase activity

Appointment

Session

Topics

Authors